Abstract:
The World Health Organization now recommends initiating all pregnant women on life-long
antiretroviral therapy (ART), yet there is limited information about the characteristics and
program outcomes of pregnant women already on ART in Africa. Our hypothesis was that
pregnant women comprised an increasing proportion of those starting ART, and that subgroups
of these women were at higher risk for program attrition